APT(SH:688617) Sou Hu Cai Jing·2025-04-18 11:04Group 1 - The core viewpoint of the article highlights the performance and market position of Huatai Medical, which closed at 432.84 yuan with a PE ratio of 62.39 times, significantly higher than the industry average of 43.49 times [1][2] - Huatai Medical's total market capitalization is reported at 42.021 billion yuan, ranking 101st in the industry based on PE ratio [1][2] - The company specializes in the research, production, and sales of cardiovascular interventional medical devices, with its electrophysiological electrode catheters being the first domestically approved products, establishing it as a leading manufacturer in the domestic electrophysiology market [1] Group 2 - For the third quarter of 2024, Huatai Medical reported a revenue of 1.525 billion yuan, reflecting a year-on-year increase of 25.63%, and a net profit of 528 million yuan, up 30.97% year-on-year, with a gross profit margin of 72.69% [1] - As of the latest report, only one institution holds shares in Huatai Medical, with a total of 6000 shares valued at 0.02 million yuan [1]